QTTB (q32bio.com) Net Profit

QTTB (q32bio.com) - company brandmark

Q32 Bio Inc. (QTTB) bases its strategy on developing antibodies to combat complement pathologies, relying on ADX-097 tests. Barriers to entry are driven by prolonged research and strict patent control. Venture potential is amplified by alliances with industry behemoths. The company's net profit metric visualizes these trends, where the value 0.03 serves as the baseline indicator of current financial dynamics.

QTTB (Q32 Bio Inc.) Net Profit history from 03/27/2024 to 10/29/2026
Core merchandise of Q32 Bio Inc

For Q32 Bio Inc., a pre-revenue company in the clinical trial stage, this indicator reflects the cash burn rate through the difference between all income and total expenses. Analyzing the company's gross profit allows for an assessment of the issuer's financial stability amid rising medical development costs, turning this chart into a detector of operational efficiency and a key tool for controlling investment risks.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN - Company Net Income|Annual Net Income Pharming Corp (PHAR)|NKTR (Nektar Therapeutics) - Net Income|UPB (upstreambio.com) - Company Net Income|Net Income ZBIO|IMNM: Final Profit|Net Profit GOSS|Company Net Income KALV (KalVista Corp)|Net Profit SEPN (Septerna Inc)|Net Financial Result pieris.com (PVLA)|SVRA - Company Net Income|Company Net Income Rigel Pharma|ANAB (AnaptysBio Corp) - Net Income|Astria Corp - Final Profit|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics Inc. - Company Profit|Net Profit KYTX (Kyverna)|TLSA - Net Income|CABA: Net Income|Net Financial Result ventyxbio.com VTYX|Theratechnologies (THTX) - Company Net Income|Annual Net Income Avalo Therapeutics, Inc. AVTX|Net Income ELDN|AGEN (Agenus, Inc) - Profit After Payment of Taxes|Net Income CLYM (Climb Bio Inc)|Profit After Payment of Taxes ZURA|Net Profit ATYR (aTyr Pharma)|Adagene Inc - Company Net Income|IMA - Company Net Income|Profit After Tax STTK|EQ: Net Profit|Connect Biopharma Holdings Limited - Final Profit|IMUX (Immunic Therapeutics) - Net Profit|Net Profit Atara Biotherapeutics Inc|Company Net Income InflaRx N.V. (IFRX)|XFOR (X4 Pharmaceuticals, Inc) - Final Profit|Company Net Income Adicet Bio, Inc. ACET|CELU - Net Income|INmune Bio - Net Profit|BRNS - Net Profit|KZR (Kezar Life Sciences, Inc) - Net Income|SAB Biotherapeutics Inc - Final Profit|AKTX (Akari Therapeutics) - Net Profit|Enlivex Therapeutics, Ltd. (ENLV) - Net Financial Result|Company Net Income GeoVax (GOVX)|Net Income Edesa Biotech Inc EDSA|Company Net Income iBio Corp IBIO|CARM - Net Income|XTLB: Net Income|BOLT - Net Profit|hcwbiologics.com (HCWB) - Company Net Income|Company Profit APVO|AIM (AIM ImmunoTech) - Net Profit|Company Net Income Aditxt Corp ADTX|Company Net Income GRI Bio, Inc. (GRI)|xortx.com (XRTX) - Annual Net Income|Vyome Holdings - Net Income|Revelation Biosciences Inc - Company Net Income|INDP: Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|AFMD (Affimed N.V.) - Company Net Income|ALLK (Allakos Inc) - Net Profit|HOOKIPA (HOOK) - Net Financial Result|Company Net Income IGM Biosciences, Inc. (IGMS)|ITOS - Company Net Income|Ocean Biomedical, Inc. - Net Income|Final Profit TCBP|Third Harmonic Bio, Inc. - Net Profit